Literature DB >> 1976690

Hybrid or multifactorial drugs in antihypertensive treatment.

P A van Zwieten.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1976690     DOI： 10.1097/00004872-199008000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  5 in total

Review 1.  An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.

Authors:  P A van Zwieten
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.

Authors:  D Boschi; A Di Stilo; C Cena; M Lolli; R Fruttero; A Gasco
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

Review 3.  The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment.

Authors:  P A van Zwieten
Journal:  Clin Investig       Date:  1992

Review 4.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

5.  The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema.

Authors:  W Schreiber; C Woisetschläger; M Binder; A Kaff; H Raab; M M Hirschl
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.